# US 2015/0148408 A1 · Heterocyclic modulators of cannabinoid receptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148408 A1
- Document ID: US20150148408A1
- Status: Published application
- Kind: A1
- Application number: 14/611,499
- Filed: 2015-02-02
- Published: 2015-05-28
- Earliest claimed: 2007-07-13
- Assignees: The Cleveland Clinic Foundation
- Applicants: The Cleveland Clinic Foundation
- Inventors: Mohamed Naquib Attala; Philippe Diaz
- Web page: https://patentgrep.com/patent/US20150148408A1

## CPC

- C07D 307/79: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61K 31/351: not condensed with another ring
- C07D 307/80: Radicals substituted by oxygen atoms
- C07D 307/81: Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C07D 405/10: linked by a carbon chain containing aromatic rings
- C07D 407/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Heterocyclic compounds which modulate cannabinoid receptors are presented. Pharmaceutical compositions containing these compounds, methods of using these compounds as modulators of cannabinoid receptors and processes for synthesizing these compounds are also described herein.

## Claims

### Claim at position 1

-38. (canceled)

### Claim 39

A method of modulating a cannabinoid receptor comprising contacting the cannabinoid receptor with a compound of formula structure I:
or a salt, ester or prodrug thereof, wherein:
R1 is selected from the group consisting of NH, NHR4, NR4R5, any carbon atom of which may be optionally substituted;
R2 is selected from the group consisting of hydrogen, aryl, alkyl, cycloalkyl, aralkyl, alkenyl, and alkynyl, any carbon atom of which may be optionally substituted;
R3 is selected from the group consisting of hydrogen, halogen, alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl, any carbon atom of which may be optionally substituted; and
R4 and R5 vary independently and are selected from the group consisting of aryl, alkyl, cycloalkyl, aralkyl, alkenyl, and alkynyl, any carbon atom of which may be optionally substituted.

### Claim 40 (depends on 39)

The method of claim 39, wherein the compound is selected from the group consisting of:
